Status of Sentinel Lymph Node Biopsy in Endometrial Cancer.

endometrial cancer sentinel lymph node sentinel mapping ultrastaging

Journal

Geburtshilfe und Frauenheilkunde
ISSN: 0016-5751
Titre abrégé: Geburtshilfe Frauenheilkd
Pays: Germany
ID NLM: 0370732

Informations de publication

Date de publication:
May 2021
Historique:
received: 27 07 2020
accepted: 01 03 2021
entrez: 26 5 2021
pubmed: 27 5 2021
medline: 27 5 2021
Statut: ppublish

Résumé

The role of lymphadenectomy in surgical staging remains one of the biggest controversies in the management of endometrial cancer. The concept of sentinel lymph node biopsy in endometrial cancer has been evaluated for a number of years, with promising sensitivity rates and negative predictive values. The possibility of adequate staging while avoiding systematic lymphadenectomy leads to a significant reduction in the rate of peri- and postoperative morbidity. Nevertheless, the status of sentinel lymph node biopsy in endometrial cancer has not yet been fully elucidated and is variously assessed internationally. According to current European guidelines and recommendations, sentinel lymph node biopsy in endometrial cancer should be performed only in the context of clinical studies. In this review article, the developments of the past decade are explored concisely. In addition, current data regarding the technical aspects, accuracy and prognostic relevance of sentinel lymph node biopsy are explained and evaluated critically.

Identifiants

pubmed: 34035551
doi: 10.1055/a-1228-6189
pii: 12286189
pmc: PMC8137276
doi:

Types de publication

Journal Article

Langues

eng

Pagination

562-573

Informations de copyright

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).

Déclaration de conflit d'intérêts

Conflict of Interest/Interessenkonflikt The authors declare that they have no conflict of interest./Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.

Références

Am J Obstet Gynecol. 2012 Jun;206(6):500.e1-11
pubmed: 22546083
Gynecol Oncol. 2015 Jun;137(3):436-42
pubmed: 25870917
Oncologist. 2016 Apr;21(4):461-6
pubmed: 26961924
Gynecol Oncol. 2019 Jun;153(3):496-499
pubmed: 31230614
Int J Gynecol Cancer. 2015 May;25(4):657-64
pubmed: 25647255
Am J Obstet Gynecol. 2017 May;216(5):459-476.e10
pubmed: 27871836
J Minim Invasive Gynecol. 2019 Sep - Oct;26(6):1125-1132
pubmed: 30445188
Lancet. 2009 Jan 10;373(9658):125-36
pubmed: 19070889
Gynecol Oncol. 2014 Aug;134(2):287-92
pubmed: 24823647
Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):373-80
pubmed: 9226326
J Clin Oncol. 2006 Jan 1;24(1):36-44
pubmed: 16330675
Eur J Gynaecol Oncol. 2001;22(2):118-21
pubmed: 11446474
Am J Obstet Gynecol. 2000 Jun;182(6):1506-19
pubmed: 10871473
BMC Womens Health. 2017 Jul 25;17(1):50
pubmed: 28743274
Gynecol Oncol. 2019 Jun;153(3):500-504
pubmed: 30902369
Gynecol Oncol. 2012 Jul;126(1):25-9
pubmed: 22507531
Gynecol Oncol. 2015 Jan;136(1):54-9
pubmed: 25450151
Eur J Cancer. 2019 Jul;116:77-85
pubmed: 31181536
Gynecol Oncol. 2018 Nov;151(2):235-242
pubmed: 30177461
Gynecol Oncol. 2017 Dec;147(3):541-548
pubmed: 28965698
Lancet. 2010 Apr 3;375(9721):1165-72
pubmed: 20188410
Eur J Cancer. 2017 Jul;79:81-89
pubmed: 28463759
Int J Gynecol Cancer. 2011 Apr;21(3):511-6
pubmed: 21436699
Gynecol Oncol. 2019 Jun;153(3):670-675
pubmed: 30833134
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1089-1109
pubmed: 30581199
Gynecol Oncol. 2017 Oct;147(1):18-23
pubmed: 28716308
Gynecol Oncol. 2017 Aug;146(2):234-239
pubmed: 28528918
Gynecol Oncol. 2019 Jun;153(3):676-683
pubmed: 30952370
Gynecol Oncol. 2008 Oct;111(1):62-7
pubmed: 18625518
Gynecol Oncol. 1996 Aug;62(2):169-73
pubmed: 8751545
Gynecol Oncol. 2020 Jan;156(1):62-69
pubmed: 31776037
Diagnostics (Basel). 2020 Sep 16;10(9):
pubmed: 32947918
Gynecol Oncol. 2016 Mar;140(3):394-9
pubmed: 26747778
Lancet Oncol. 2011 May;12(5):469-76
pubmed: 21489874
Int J Gynecol Cancer. 2019 Mar;29(3):513-517
pubmed: 30833439
Int J Gynecol Cancer. 2013 Jun;23(5):964-70
pubmed: 23694985
Int J Gynecol Cancer. 2020 Mar;30(3):311-317
pubmed: 31992599
Lancet Oncol. 2018 Oct;19(10):1394-1403
pubmed: 30143441
Int J Gynecol Cancer. 2017 May;27(4):743-747
pubmed: 28375931
Gynecol Oncol. 2009 Nov;115(2):236-8
pubmed: 19666190
Gynecol Oncol. 2014 Aug;134(2):281-6
pubmed: 24882555
Ann Surg Oncol. 2016 May;23(5):1653-9
pubmed: 26714954
Gynecol Oncol. 2012 Oct;127(1):5-10
pubmed: 22771890
J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16
pubmed: 19033573
Ann Oncol. 2016 Jan;27(1):16-41
pubmed: 26634381
Gynecol Oncol. 2017 Aug;146(2):240-246
pubmed: 28577885
Int J Gynecol Cancer. 2009 Apr;19(3):391-4
pubmed: 19407565
Gynecol Oncol. 2017 Aug;146(2):405-415
pubmed: 28566221
Gynecol Oncol. 2017 Dec;147(3):528-534
pubmed: 29032824
Lancet Oncol. 2017 Mar;18(3):384-392
pubmed: 28159465
Clin Nucl Med. 2016 Dec;41(12):927-932
pubmed: 27749429
J Cancer Res Clin Oncol. 2017 Mar;143(3):475-480
pubmed: 27812854
Geburtshilfe Frauenheilkd. 2018 Oct;78(10):949-971
pubmed: 30364388
Int J Gynecol Cancer. 2020 Jan;30(1):41-47
pubmed: 31780567
Cancer. 1977 Feb;39(2):456-66
pubmed: 837331
Int J Gynecol Cancer. 2015 Jul;25(6):1044-50
pubmed: 25853384
Int J Gynecol Cancer. 2015 Jan;25(1):81-6
pubmed: 25347094
Gynecol Oncol. 2019 Nov;155(2):177-185
pubmed: 31604668
Gynecol Oncol. 2014 Jun;133(3):506-11
pubmed: 24642092
Int J Gynecol Cancer. 2019 Jan;29(1):60-67
pubmed: 30640685
Ann Oncol. 2007 Nov;18(11):1799-803
pubmed: 17709801
Gynecol Oncol. 2009 Dec;115(3):453-5
pubmed: 19767064
Ann Surg Oncol. 2017 Jul;24(7):1972-1979
pubmed: 28265777
Bull Cancer. 2007 Jan;94(1):E1-4
pubmed: 17236998
Ann Surg Oncol. 2016 Jan;23(1):196-202
pubmed: 25994210
Gynecol Oncol. 2013 Nov;131(2):299-303
pubmed: 23988415
Am J Obstet Gynecol. 2019 Mar;220(3):263.e1-263.e8
pubmed: 30521798
Gynecol Oncol. 2017 Dec;147(3):549-553
pubmed: 28942993
Int J Gynecol Cancer. 2019 Sep;29(7):1121-1125
pubmed: 31320490
Ann Surg Oncol. 2016 Jul;23(7):2183-91
pubmed: 26714944
Med Teach. 2011;33(2):105-15
pubmed: 21275542
Gynecol Oncol. 2009 May;113(2):163-9
pubmed: 19232699
J Am Coll Surg. 2001 Aug;193(2):206-9
pubmed: 11491451
J Natl Compr Canc Netw. 2018 Feb;16(2):170-199
pubmed: 29439178
Oncologist. 2009 Jul;14(7):695-705
pubmed: 19608640
Int J Gynecol Cancer. 2019 Mar;29(3):613-621
pubmed: 30712017
Gynecol Oncol. 2007 May;105(2):457-61
pubmed: 17313975
South Med J. 1999 Feb;92(2):204-8
pubmed: 10071668
Gynecol Oncol. 2016 May;141(2):206-210
pubmed: 26905211

Auteurs

Florin Andrei Taran (FA)

Klinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg, Germany.

Lisa Jung (L)

Klinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg, Germany.

Julia Waldschmidt (J)

Klinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg, Germany.

Sarah Isabelle Huwer (SI)

Klinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg, Germany.

Ingolf Juhasz-Böss (I)

Klinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg, Germany.

Classifications MeSH